Di ikɔnomi klaymat fɔ aesthetic medicine de chenj. Fɔ lɔng tɛm naw, di klinik dɛn dɔn mek dɛn injɛktabl tritmɛnt program pan di brand dɛn we pipul dɛn sabi fɔ ful-ɔp di hyaluronic acid, ɛn dɛn dɔn tek di prayz ɛn prɔfit strɔkchɔ we di big big manifakta dɛn dɔn tɛl dɛn. Bɔt insay wan makit we de aksɛleret medical aesthetics market growth , wit kɔmpitishɔn we de ɔt ia afta ia, smat klinik ɔpreshɔn dɛn dɔn bigin fɔ aks dɛnsɛf wan impɔtant kwɛstyɔn: wetin mek a fɔ spɛn mi tray fɔ promot ɔda pɔsin in brand?
Di ansa na dat di pruf dɛn de se yu nɔ fɔ du dat mɔ ɛn mɔ. Dis atikul go ɛksplɔrɔ di kɔmplit biznɛs kes fɔ divɛlɔp yu yon dɛmal fil layn. Dis nɔto jɔs wan nich ɛkspiriɛns, bɔt na stratejik impɔtant fɔ klinik dɛn we de pe atɛnshɔn fɔ maksimayz dɛn ROI, bil pasɛnt lɔyalti ɛn mek shɔ se dɛn gɛt lɔng tɛm prɔfitabiliti. Na dis transfɔmeshɔnal joyn, di sɛlɛkshɔn fɔ wan manufakchurin patna we gɛt glob ɔl ɛkspiriɛns ɛn bak kɔstɔm kapabiliti na bɔku tɛm di difrɛns bitwin sakrifays ɛn fayl.
Maket Landskɛp: Taym nɔ bin ebul fɔ bɛtɛ
Bifo wi go insay di 'aw fɔ,' lɛ wi fɔs analayz di 'wetin mek naw.' Di global mɛdikal aesthetics makit bin gɛt valyu fɔ $17.3 bilyan insay 2024. Dɛn se di makit go rich $19.54 bilyan insay 2025 ɛn dɛn prɔjɛkt se i go gro to $40.7 bilyan bay 2031, we go rɛjista wan Kɔmpawnd Annual Growth Rate (CAGR) di 13.0%. Bɔt ivin insay dis big mɛdikal aesthetics kɔntɛks, hyaluronic acid fillers nɔmɔ na big ɛn fast-grɔw pat pan di makit. Di glob ɔl hyaluronic acid filler market gɛt valyu fɔ $5.15 bilyan insay 2025 ɛn dɛn projɛkt fɔ rich $9.91 bilyan bay 2034, wit CAGR we na 7.8%.
Dɛn nɔmba ya nɔto jɔs dray statystik bɔt bɔku bɔku injɛkshɔn dɛn we dɛn kin du ɛvri ia ɛn injɛkshɔn dɛn kin de ɔltɛm pan di mɛdikal aesthetic prosidur dɛn we dɛn kin du pas ɔl na di wɔl. Di big big pat pan di fil dɛm we de na di makit na bays pan hyaluronic acid, wit dɛn sefty profayl ɛn prɛdiktibɛl rizɔlt, ɛn di dimand fɔ dɛn prɔdak ya de go ɔp ɔltɛm na ɔl di ej grup dɛm.
Na di sem tɛm, di sapɔt chen fɔ aesthetic fillers de ɔnda wan silent yet profaund transfɔmeshɔn. Chaina dɔn kɔmɔt as wan big big wɔl fɔ mek tin dɛn, usay bɔku bɔku manifakta dɛn—we gɛt intanashɔnal GMP sɛtifiket dɛn—de prodyuz prɔdak dɛn we mit, ɛn insay sɔm kes dɛn ivin pas, di kwaliti standad dɛn fɔ tradishɔnal Wɛstinian brand dɛn. Tek AOMA, fɔ ɛgzampul: wan kɔmni we gɛt pas tu dikɔs dip ɛkspɛriɛns pan di mɛdikal ɛstɛtiks ɛkspɔt sɛktɔ. Tide, dɛn de ɛkspɔt in prɔdak dɛn to pas 120 kɔntri dɛn inklud di makit dɛn na di EU ɛn di US Di fam na patna we dɛn kin trɔst, we dɔn de fɔ lɔng tɛm fɔ bɔku ovasi klinik dɛn, di dilɛs dɛn ɛn distribyushɔn dɛn. Impɔtant tin na dat, di dairekt prayz we dɛn kin bay frɔm dɛn kayn manifakta dɛn de, na wan smɔl pat pan di rital prays fɔ tradishɔnal brand dɛn. Dis manufakchurin kapabiliti dɔn opin wan spɛshal chans fɔ klinik dɛn fɔ patna dairekt wit ɛkspiriɛns manifakta dɛn fɔ divɛlɔp dɛn yon branded layn dɛn fɔ aesthetic fillers, baypas multi-layered distribution channels.
Dis kin rilizɔt wan biznɛs mɔdel we de pul layers fɔ mak-ap we de alaw klinik dɛn fɔ ol di ful prɔfit margin pan ɛni ɛn ɛvri sirinj we dɛn administret. Fɔ di klinik dɛn we gɛt bɔku bɔku pipul dɛn—dɛn wan dɛn we de du bɔku bɔku fila tritmɛnt dɛn ɛvri mɔnt—di faynɛns impak we dis shift gɛt rili chenj.
ROI Kalkyuleshɔn: Wetin Mek In-Haus Fila Na Gem Chenj
So wetin i min rili we klinik chenj frɔm we dɛn de sɛl ɔda brand dɛn fɔ fil to put in yon brand na makit? Di data de tɛl wan stori we rili kɔmplit.
Gros margin fɔ hyaluronic acid filers in di medikal aesthetics ɛn spa industri jɔs de frɔm 40% to 60%, bays pan industri bɛnchmak data. I rɛspɛktful, bɔt i de sho bak di ay prodak kɔst we klinik dɛn de gɛt we dɛn de bay brand dɛn we pipul dɛn sabi we inklud di big big makɛt badjɛt, distribyushɔn mak-ap ɛn brand prɛmiɔm.
Klinik dɛm we de mek dɛn yon prɔpriet brand fɔ fil kin si gros margin bitwin 55 ɛn 70 pasɛnt, bɔt. Dis inkris we na 15 to 30 pasɛnt poɛnt de translet dairekt to net prɔfit. Wan klinik we de du 200 fil tritmɛnt dɛn wan mɔnt wit avɛrej kɔst fɔ $200 fɔ wan sirinj frɔm tɔd-pati brand dɛn kin si ɔda $14,000+ insay gros prɔfit fɔ wan mɔnt bay we dɛn go tru wan prɔpriet brand fɔ kɔt kɔst bay 30%. Dis na di ikwal fɔ ad bɔku ay-margin savis to di klinik in ɔfrin dɛm, we nɔ go inkrisayz di pasɛnt volyum.
Biyond Sirinj Ikɔnomi: Brand Prɛmiɔm
Di ikɔnomi bɛnifit frɔm wan klinik we de gi in yon brand fɔ dɛmal filɛs go fa pas fɔ jɔs kɔt di sapɔt kɔst. Wan prɔpriet prodak layn de prodyuz wetin di industri kɔnsaltɛnt dɛn kɔl 'staggering profit margins,' we i de mek bak di kɔstɔma lɔyalti ɛn fuel ripit biznɛs. Di wan dɛn we sik we kin abop pan di pɔsin we de gi dɛn di tin dɛn we dɛn nid, kin abop pan di prɔdak dɛn we di pɔsin we de gi dɛn di mɛrɛsin kin advays dɛn—ɛn we dɛn mek. Dis trɔst de translet dairekt to prayz pawa.
Fila frɔm establish brand brand dɛn de tru bɔku chanɛl dɛn, ɛn bɔku tɛm di pasɛnt dɛn kin fɛn dɛn pan diskɔnt ret na di intanɛt. Bɔt yu prayvet-lɛbul brand—we na wan manifakta we yu pik nɔmɔ mek—na yu klinik nɔmɔ de. Dis eksklusiti de pul prayz shopin ɛn alaw yu fɔ kɔmand prɛmiɔm fɔ di yunik valyu prɔpɔshɔn we yu prɔpriet fɔmyulashɔn de ɛmbodi.
Aw fɔ stat wan kɔstɔm fil layn
Di rod fɔ divɛlɔp wan pasɔnal layn fɔ dɛmal fil dɛm nɔ ɛva bi mɔ aksesbul fɔ klinik ɔpreshɔn ɛn aesthetic mɛdikal administreta dɛm we rɛdi fɔ di nɛks step. Dis na step by step ditayl prɔses fɔ mek dis frɔm skrach.
Aw fɔ stat kɔstɔm fil layn i bigin wit klia klinik vishɔn. Wetin na di pesin nid ɔr aesthetic gol dɛm wae yu klinik spɛshal pan? Sɔntɛm dɛn sabi yu fɔ yu natura l lip kɔntɔring ɔ yu klinik na fɔ bɔku pasɛnt dɛn we want fɔ briŋ bak volyum to dɛn fes – lɛk afta dɛn dɔn lɔs bɔku bɔku weit. Yu prɔpriet fɔmyulashɔn fɔ sho yu klinik trɛnk.
Di klinik brand dɛm we gɛt mɔ sakrifays nɔ de tɔk insay jenɛral tin dɛm; dɛn kin tɛl dɛn yon spɛshal stori ɛn adrɛs sɔm patikyula tin dɛn we pɔsin kin wɔri bɔt. We yu patna wit wan manifakta we gɛt bɔku laybri fɔ fɔmyulashɔn, yu kin divɛlɔp customized hyaluronic acid formulas tailored specifically to your patient demographic and injection techniques.Fɔ ɛgzampul, AOMA de kip wan rizɔv we gɛt pas 1,000 fɔmulashɔn dɛn we dɛn dɔn establish ɛn i de yuz wan tim we gɛt fayv ɛkspɛkt dɛn—ɛvri wan gɛt avɛj pas 20 ia prɔfɛshɔnal ɛkspiriɛns—we kin gi klinik dɛn prɛsis rɛkɛmɔndeshɔn fɔ fayn-tyun paramita dɛn we de frɔm HA kɔnsɛntreshɔn ɛn krɔs-link digri to patikyula saiz distribyushɔn, we de ɛp klinik dɛn fɔ mek rili difrɛn prɔdak dɛn.
Step Tu: No ɛn Pik di Rayt Manufakchurin Patna—Wetin Mek AOMA Na fayn tin fɔ tink bɔt
Dis step rili impɔtant. Nɔto ɔl di wan dɛn we de mek hyaluronic acid filers na pipul dɛn we dɛn kin abop pan; we i kam pan di sikman sef, kwaliti nɔ kin kɔmprɔmis. Yu manufakchurin patna fɔ bi pɔsin we kwalifay ɔlsay na di wɔl ɛn we gɛt ɛkspiriɛns GMP-sɛtifiket manifakta, we gɛt kwaliti rɛkɔd we pɔsin kin tray fɔ prodyuz injɛkshɔn mɛdikal divays dɛn we de fala intanashɔnal rigyuletɔri standad dɛn.
Insay dis, AOMA—wit in pas 20 ia ɛkspiriɛns na di mɛdikal ɛstɛtiks ɛkspɔt sɛktɔ—dɔn ɔlrɛdi gi wan difinitiv ansa tru in yon kɔntinyu fɔ gɛda ɛkspɛriɛns. Di kɔmni gɛt ISO 13485 sɛtifiket; in prɔdak dɛn dɔn gɛt EU CE mak ɛn bɔku intanashɔnal rɛjista dɛn; ɛn in fasiliti dɛn gɛt wan Klas 100 GMP prodakshɔn wokshɔp—di ay standad insay di famasi industri. I filin ɛn sterilayz ikwipmɛnt kɔmɔt frɔm di tɔp-taya Yuropian spɔlayt dɛn—lɛk Jamani in OPTIMA ɛn Swidan in GETINGE—so dat de mek shɔ se di ɛndotoksin lɛvɛl ɛn steriliti barɛri fɔ ɛvri wan fil prodak mit di strɔng standad dɛn we dɛn nid fɔ mɛdikal injɛkshɔn.
Bɔt wetin rili mek AOMA difrɛn frɔm di bɔku bɔku manifakta dɛn na di dip ɔndastandin we i gɛt bɔt di patikyula nid dɛn we ovasi klinik ɛn distribyushɔn dɛn gɛt. As ɛntapraiz we dɔn de sav di glob ɔl makɛt fɔ lɔng tɛm, AOMA no gud gud wan aw fɔ ɛp in klaynt dɛn fɔ sɔlv prɛktikal chalenj dɛn:
● Lɔw minim ɔda kwantiti ɛn fleksibul lida tɛm: AOMA de aksept fɔs ɔda dɛn we smɔl lɛk 500 yunit ɛn i de kip wan stebul avɛrej lida tɛm we na 2 to 3 wiks, we de alaw klinik dɛn fɔ lanch dɛn yon prayvet lɛbl dɛn we nɔ nid fɔ kip bɔku invɛntari.
● Jɛnɛral Kastɔm Manufakchurin Kapabiliti: AOMA nɔ de sɛl bak di fɔmyulashɔn dɛn we dɔn de, we nɔ de na di shelf ɔnda prayvet lɛbl. Wi gɛt tru tru kɔstɔm manufakchurin kapabiliti fɔ dɛmal fillers. Yu kin ajɔst di HA kɔnsɛntreshɔn, krɔslinkin tɛknɔlɔji, jel kɔhivnɛs, ɛn ivin injɛkshɔn fɔs fɔ mit spɛshal klinik nid dɛn, so dat yu go divɛlɔp wan klinik tul we na yu yon.
● Fri Sampl ɛn Klinik Trayal Sɔpɔt : Bifo dɛn prodyuz bɔku bɔku wan, AOMA kin gi klinik dɛn sɛmpul fɔ intanɛnt ɛvalueshɔn ɛn limited klinik ɔbshɔbishɔn, we de alaw yu fɔ go bifo wit yu fɔmal ɔda wit kɔmplit kɔnfidɛns.
We wan manifakta gɛt GMP sɛtifiket, gɛt in-haus R&D tim, Klas 100 prodakshɔn ɛnvayrɔmɛnt, istri fɔ ɛkspɔt to pas 120 kɔntri dɛn ɔlsay na di wɔl, lɔw minim ɔda kwantiti (MOQ), ɛn i de gi fri sɛmpul, dɛn kin stɔp fɔ bi jɔs saplay ɛn bi stratejik patna fɔ yu klinik in brand transfɔmeshɔn.
Step 3: Kɔndɔkt rigyuletɔri ɛn kɔmplians du dilayjens.
Wan gud patna fɔ mek tin dɛn go gi yu di prɔses dɛn we dɛn dɔn validet bifo tɛm ɛn ɔl di rigyuletɔri dɔkyumentri we yu nid—lɛk dizayn istri fayl dɛn, tɛknikal dɔkyumentri, bayɔkompatibiliti ripɔt, ɛn klinik ɛvalueshɔn sɔmari. Dɛn dɔkyumɛnt ya go ɛp fɔ mek yu prɔdak in tɛm fɔ go na makit kwik kwik wan, ɛn dis go ridyus di tɛm we yu nid fɔ du indipɛndɛnt klinik trial frɔm 12 to 18 mɔnt to jɔs smɔl pat pan da tɛm de.
Bɔku tɛm, manifakta dɛn we gɛt ɛkspiriɛns pan ɛkspɔt kin tek di fɔs tin fɔ ɛp dɛn klaynt dɛn bay we dɛn kin gi kɔnsaltin savis fɔ rɛjista prɔdak na dɛn target makit dɛn. AOMA kin gi rigyuletɔri kɔmplians sɔpɔt dɔkyumentri we dɛn tayla to di klaynt nid akɔs difrɛn rijyɔn dɛn—inklud di EU, di US, di Midul Is, ɛn Sawt Is Eshia—fɔ ɛp klinik dɛn fɔ mek shɔ se dɛn fala di lokal rigyuleshɔn dɛn.
Ivin if nɔto yu de mek di prɔdak, yu stil gɛt di wok fɔ mek shɔ se ɛni prɔdak we yu yuz na yu klinik de fala ɔl di sef ɛn lɔ dɛn we de naw insay yu lokal kɔntri. Kɔlabɔt wit yu ligal advays ɛn mɛdikal dairekta fɔ mek dɛn mek di rayt prɔses fɔ ɛvaluet di prɔdak, fɔ ripɔt bad tin dɛn we apin, ɛn fɔ mek di pɔsin gri fɔ du sɔntin we dɛn no bɔt..
Step 4: Ditarmin Minimum Ɔda Kwantiti ɛn Invɛntari Strateji
Minim Ɔda Kwantiti (MOQ) rikwaymɛnt dɛn dɔn bi wan impɔtant tin fɔ lɔng tɛm fɔ mek prayvet lɛbl; bɔt dɛn dimand ya dɔn bi mɔ fleksibul tank to inkris efyushɔn insay di manifakta dɛn sapɔt chen. Tide, bɔku establish manifakta dɛn de gi sɔlvishɔn wit fɔs ɔda we smɔl lɛk 500 yunit, we de alaw klinik dɛn fɔ tɛst nyu prɔdak pan patikyula pasɛnt pipul dɛn bifo dɛn kɔmit fɔ big-skel prodakshɔn rɔn.
Dɔn bak, di manifakta dɛn kin gi bak wan 'prɔdakshɔn-ɔn-dimand' mɔdel fɔ klinik dɛn we de wɔri bɔt di kɔst fɔ ol invɛntari, we de alaynɛs di prodakshɔn schedule wit di aktual sɛl pefɔmɛns. Dis we ya de ridyus di kapital we dɛn tay pan invɛntari ɛn mek shɔ se dɛn gɛt stedi saplai fɔ di prɔdak dɛn.
Insay aesthetic medicine, pakej impɔtant jɔs lɛk di fɔmyulashɔn insɛf fɔ gi infɔmeshɔn bɔt di kwaliti fɔ di prɔdak. Kastom mɛdikal pak fɔ sho yu brand in prɛmiɔm pozishɔn ɛn fɔ fala ɔl di rigyuletɔri rikwaymɛnt fɔ mɛdikal divays lɛbl. Kɔlabɔt wit yu manufakchurin patna fɔ mek pak we go fayn fɔ si jɔs lɛk aw i go gri wit di klinik.
Insay dis, AOMA in kɔstɔm pak savis fɔ gɛt spɛshal rɛkɔgnishɔn. Di klinik dɛn kin pik frɔm bɔku difrɛn sirinj ɛn nidul spɛsifikɛshɔn kɔmbaynshɔn dɛn, ɛn dɛn kin kɔstɔmayt di tin dɛn we dɛn yuz fɔ di ɔda bɔks, di we aw dɛn kin print, di liflet dɛn we de gi infɔmeshɔn, ɛn di tin dɛn we dɛn kin yuz fɔ mek pipul dɛn no bɔt di prɔdak. Ivin mɔ impɔtant, AOMA kin disayn di pak frɔm skrach—bays pan yu brand in vijual aydentiti sistɛm—fɔ mek shɔ se yu klinik in prayvet lɛbl prodak dɛn de projɛkt wan pɔshɔnal, ay-ɛnd imej rayt frɔm di biginin.
Ikual impɔtant na fɔ divɛlɔp kɔmprɛhnsiv pasɛnt ɛdyukeshɔn matirial dɛm we de kɔmyuniket klia wan di spɛshal bɛnifit dɛm, sefty kɔnsidareshɔn dɛm, ɛn klinik ɛfifikɛshɔn fɔ yu ɛksklusiv fɔmyulashɔn dɛm. Transparency ɛn profeshɔnal gayd kin bi pawaful tin fɔ mek pipul dɛn gɛt trɔst we di sik pipul dɛn si se na pɔsin we dɛn trɔst dɔn mek wan prɔdak—wan we, pan ɔl dat, ebul fɔ gi bɛtɛ rizɔlt.
Kɔmpitishɔn Advantej: Bifo Faynanshɛl Ritɔns
Di faynɛns argumɛnt fɔ wan prɔpriet filɛ brand rili kɔmplit bɔt ɔda nɔ-faynanshɛl advantej dɛn de we na rili impɔtant stratejik kɔnsidareshɔn dɛn bak.
Di Peshɛnt Loyalti ɛn Ritɛnshɔn
Di faynɛns argumɛnt fɔ wan prɔpriet filɛ brand rili kɔmplit bɔt ɔda nɔ-faynanshɛl advantej dɛn de we na rili impɔtant stratejik kɔnsidareshɔn dɛn bak. As wan masta sabi pɔsin we sabi bɔt di industri bin tɔk: 'If di wan dɛn we sik fɔ kam bak fɔ bay mɔ prɔdak, dis kin mek di kɔstɔma dɛn kɔntinyu fɔ de ɛn di wan dɛn we sik kin de biɛn dɛn.'
Klinik Ɔtonomi ɛn Fɔmulari Kɔntrol
Tɔd-pati brand dɛn nɔ jɔs de dikte di prayz bɔt dɛn de dikte bak di patikyula kwaliti dɛn fɔ di fɔmyulashɔn. We yu de kɔntrol di fɔmyulashɔn, na yu de kɔntrol di klinik tul. WAN kɔstɔmayz hyaluronic acid fכmula kin optimiz dipεnd pan yu spεsifi k injεkshכn tεknik εn pasεnt populeshכn—if na bay we yu adjɔst di G' valyu fכ achy supεriכr strכkchכral sכpכt, altεr kכhεsiviti fכ fεsilitεt tisu intagrεshכn, כ bεlε di rεshכn fכ kכros-link to nכn-krכs-link HA fכ achy ideal post-injεkshכn haydreshכn.
As di makit de evolv to big pesonalizeshn en rijenereshכn, dis lεvεl fכ kכntrכl de pruv patikyula valyu. Di rijeneretiv aesthetics market de gɛt kwik growth—dɛn projɛkt fɔ ɛkspɛn frɔm $15.58 bilyan insay 2025 to $17.66 bilyan insay 2026—wit ɛkszosom-bɛs tɛrapi dɛm we de kɔmɔt as kɔmplimɛnt kategori to tradishɔnal fil dɛm. Klinik dɛn we gɛt di kapasiti fɔ divɛlɔp dɛn yon prɔdak layn dɛn go bɛtɛ pozishɔn fɔ intagret nyu teknɔlɔji dɛn ɛn fɔmulayt difrɛn kɔmbayn tritmɛnt protɔkɔl dɛn.
Di resilience to market fluktueshɔn
Sapɔt chen disrɔpshɔn, raw matirial shɔt ɛn prayz fluktueshɔn bitwin manifakta dɛn dɔn bi ɔltɛm chalenj na di mɛdikal ɛstɛtiks industri. Klinik dɛm we de abop pan tɔd pati brand nɔ gɛt bɛtɛ kɔntrol pan dɛn vayriɔbul ya. Bɔt bay we dɛn wok dairekt wit spɛshal manifakta dɛn – lɛk AOMA – we gɛt dɛn yon raw matirial fɛmɛnt sistɛm ɛn stebul prodakshɔn kapasiti, klinik dɛn kin ajɔst big sapɔt stebiliti ɛn prɛdiktibɛl kɔst – tu tin dɛn we rili impɔtant fɔ rili faynɛns planin.
Impɔtant Tin dɛn ɛn Tipik Mistek dɛn
Fɔ lanch yu yon brand fɔ dermal fillers na big biznɛs disizhɔn. Bifo yu tek dis step, yu fɔ pe atɛnshɔn mɔ to dɛn pɔynt dɛn ya:
Yu manufakchurin patna in kwaliti sistɛm fɔ tinap fɔ mek dɛn tek tɛm luk am gud gud wan. Rikwest dokumɛnt fɔ dɛn sɛtifiket stetɔs, ɔdit istri ɛn kwaliti mɛtrik. If i pɔsibul, chɛk dɛn rɛjista sɛtifiket fɔ yu target makɛt dɛn (ɛgz. CE, ISO 13485 ɛn ɔda wan dɛn) ɛn evalyu dɛn trak rɛkɔd fɔ ɛkspɔt to strikt rigyuleshɔn rijyɔn dɛn. AOMA in prɔdak dɛm dɔn saksesful fɔ go insay di makit dɛm na di EU, di US, Sawt Amɛrika, Sawt Is Eshia, di Midul Is, Afrika ɛn ɔdasay dɛm; dis big big rich dɔn gi wi prɛktikal ɛkspiriɛns fɔ wok tru difrɛn rigyuletɔri ɛnvayrɔmɛnt, we na invaluable intangible asset fɔ klinik dɛn we de ɛnta prayvet lɛbl fɔ di fɔs tɛm.
Di kɔmyunikeshɔn fɔ di pɔsin we sik fɔ bi transparent
Pan ɔl we yu gɛt ɔl di rayt fɔ divɛlɔp ɛn makɛt yu yon prɔdak layn, di wan dɛn we sik fɔ no gud gud wan bɔt di rayt tin we dɛn de gɛt. Divɛlɔp klia kɔmyunikeshɔn skript fɔ di sik pipul dɛn we de sho usay di tin dɛn we dɛn de yuz fɔ mek di it, di kwaliti standad, ɛn di klinik istri fɔ yu prayvet-lɛbul prɔdak dɛn.
Fɔ fala di lɔ na yu wok
Pan ɔl we yu manufakchurin patna kin gi rigyuletɔri sɛtifikeshɔn dɔkyumentri fɔ big makit dɛn—lɛk di EU ɛn di US—di ɔltimat rispɔnsibiliti fɔ fala di mɛdikal divays rigyuleshɔn dɛn na yu patikyula jɔrisdikshɔn de wit yu, as di klinik ɔpreshɔn. Mek shɔ se yu ɛngage wan ligal ɔ kɔmplians kɔnsult we gɛt ɛkspɛriɛns pan mɛdikal divays rigyuleshɔn fɔ ɔvasayz dis prɔses.
Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) na bod-sɛtifiket kɔsmɛtik sajin na Nyu Yɔk Siti wit pas 9 ia spɛshal ɛkspiriɛns pan hyaluronic acid filers, akni ska tritmɛnt, ɛn minimally invasive fes kɔntɔring. Dɛn no am mɔ fɔ in ɛkspɛriɛns pan advans injɛkshɔn tritmɛnt dɛn we de mek di akni ska dɛn layt fayn fayn wan, mek di skin wɛl, ɛn mek di skin smol smol bak tru di injɛkshɔn we dɛn dɔn tɔk bɔt fɔ mek di skin ripɛnt ɛn di tɛknik dɛn we dɛn de yuz fɔ mek di skin go bifo.
